FindTrial
Sign In

A study of the efficacy of two different doses of a drug ,clonidine, in increasing the duration of pain relief provided by a nerve blockade in children undergoing hernia surgery

To study the analgesic efficacy of two different doses of clonidine as an adjuvant to bupivacaine in ilioinguinal/iliohypogastric block in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011797
Enrollment
60
Registered
2018-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA 1 and 2 children of age 1 to 8 yrs undergoing inguinal hernia repair

Interventions

Intervention1: 0.5 % bupivacaine (0.25 ml/kg): Maximum of 5 ml given in the nerve block (group A) Control Intervention1: 0.5 % bupivacaine (0.25 ml/kg), 1 microgram/kg clonidine: Maximum 5 ml given in

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA 1 and 2 undergoing elective daycare inguinal surgery for inguinal hernia

Exclusion criteria

Exclusion criteria: 1.parent refusal 2.contraindication to regional anesthesia 3.allergy to the drugs

Design outcomes

Primary

MeasureTime frame
visual analogue score/ objective pain scale of 4Timepoint: 360 minutes—

Secondary

MeasureTime frame
sedation of 2 or moreTimepoint: 360 minutes—

Countries

India

Contacts

Public ContactDr Sree Kumar E J

AIIMS

drgpd@yahoo.com9013232965

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026